TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Patient retention in assigned study group
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: First transseptal time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of equipment exchanges
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ulnohumeral joint gapping
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resistance to valgus stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kujala, Lysholm, Tegner and IKDC scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: congruence angle and patellar tilt angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction rate of rehabilitation treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Scores of standing and walking function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean total OSATS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Cumulative probability of motor deterioration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: new detections of anal HPV infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: proportion of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Length of surgical specimens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: airway complication rate
Endpoint domain: Adverse events/effects
Primary endpoint: transition time to psychosis or dementia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: nadir IC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: peak IC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: area under the curve for 12 h after the dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Sensitivity of consensus panel diagnosis compared to CAM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinic appointment attendance
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: gains in reappraisal performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anxiety levels on operation day
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Serum C22 lactone sulfate levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient decision for one or the other procedure
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of complications or death
Endpoint domain: Mortality/survival
Primary endpoint: difference in NMSS between treatment groups
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Antitumor drug-related problems
Endpoint domain: Adverse events/effects
Primary endpoint: risk of spontaneous POS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: walking distance of 6‐Minute Walking Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average number of we-chat steps
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of scapular focused treatments for shoulder pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: patient distress
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: genetic counsellor empathy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: revision surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Degree of kinesiophobia
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Uptake of online or telephone services for health behaviors
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: RMET score improvement
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: score of compliance to examinations
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Control Attitudes Scale‐Revised (CAS‐R) score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: mobilisation out of bed during ECMO
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Impact of controlled MI on trial results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Application of problem-oriented coping strategies
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Chalder Fatigue Scale improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Fatigue
Primary endpoint: Acceptance rate of TSD therapy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Respiratory event index improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Biomarker expression changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in 131I therapeutic activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle damage biomarkers (Myoglobin, Creatine Kinase, Aldolase, Hemoglobin, Hematocrit)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Joint Space Narrowing (JSN)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oropharyngeal leak pressure before extubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IFNα protein positivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Right-sided adenoma detection rate (RC ADR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achievement of weekly goals
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Effectiveness of parents of children with obesity
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Helpfulness of parents with obesity
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Risk of advanced extraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: log sFer improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Melatonin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hematological parameters (WBC, RBC, HCT, Hb)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Complete elimination rate of core symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of PC training among volunteers
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Incidence of herpes zoster‐related disease
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of malignancies (excluding non‐melanoma skin cancer)
Endpoint domain: Adverse events/effects
Primary endpoint: AvgBIS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AvgOAA/S
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AvgCe
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of clinically relevant PPH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: violent behaviors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diabetes progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Causal coherence in turning-point narratives
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: knee functional status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: help-seeking intentions from friends
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: incidence of cis‐AKD
Endpoint domain: Adverse events/effects
Primary endpoint: time to develop cis‐AKD
Endpoint domain: Adverse events/effects
Primary endpoint: total dog-facilitated physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Benefit recipiency
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Reduction in annualised nursing resource
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Reduction in pain/discomfort
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: CP of lexical tones
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CP of VOT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1RM bench press performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time under tension during strength-endurance test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total intraoperative remifentanil dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS scores at postoperative time points
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Macronutrient distribution
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Types of foods consumed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Turn 360 decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transfusion rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Iron balance improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Identification of POAG patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ability to recall information
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction rate among patients
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Inappropriate termination of programs
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Inappropriate continuation of programs
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of anemic children
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Mean blood hemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: DSCs value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global 3D gamma passing rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interobserver agreement in Ki67 immunohistochemistry assessments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Internal marginal adaptation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of adhesive layer at the tooth-restoration interface
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prediction of pathological complete response (pCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: enhanced associative learning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: larger memory improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early type II EL occurrence
Endpoint domain: Mortality/survival
Primary endpoint: Re-intervention rate
Endpoint domain: Mortality/survival
Primary endpoint: Delivery of fall prevention programme
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: overall analgesic consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Surgical field score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: post-exercise biomarkers of liver damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: post-exercise renal function markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Prenatal distress levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Antenatal attachment levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Condom use with main partner
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of alcohol and/or other drugs before or during last sexual intercourse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric Mean Titer (GMT) of binding antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of solicited adverse reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Patterns of BV (Bacterial Vaginosis) recurrence and persistence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in the 17‐item Hamilton Rating Scale for Depression score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of B cells, TH17 cells, and activated T cells in PBMCs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Expression of TET enzymes in lymphocyte subsets
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Treatment outcomes at the group level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of the spiroergometric stress test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in NIPPV failure within 72 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Decreased requirement of surfactant
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of patients who developed shivering
Endpoint domain: Adverse events/effects
Primary endpoint: Effective rate of STER treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SLEDAI-2K score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Active joint count improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Burden of Kidney Disease
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Femoral strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reoperation or intervention within 30 days of surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Long-term control of OT-PVCs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction of calcaneus pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in function and health of feet
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of plantar load on the rearfoot, midfoot and forefoot
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in comfortable gait velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 10-year ASCVD risk score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: right medial cortical thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Lack of energy
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: mean bleeding during surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Knowledge about HIV/AIDS, TB, and T. solium
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Research awareness of the community
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cultural norms relevant to the ethical conduct of research
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Feasibility of the REA process
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rates of pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Incident HIV during pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Correlation between glucometer readings and laboratory measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean bias of glucometer readings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Drug‐liking VAS Emax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful smoking cessation at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Smoking screening
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Smoking counseling
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: global distress
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: psychological flexibility
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: improved molar relation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in the number of ocular hypotensive drugs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gastric Cleanness Grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: mean extent of MVO
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pain at sexual activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: final leakage area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: undetectable viremia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: words per minute
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chemical pregnancy rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ALT levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver enzymes outcomes
Primary endpoint: Total 7×7 questionnaire score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement on the Gastrointestinal Symptom Rating Scale-IBS version
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: COX‐1 and COX‐2 activity inhibition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain scores on cough
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart failure events during follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of satisfactory surgical condition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Postprandial rise in glucose Ra
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Postprandial plasma insulin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: predicted median survival time
Endpoint domain: Mortality/survival
Primary endpoint: Objective comprehension score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Freedom from recanalization
Endpoint domain: Mortality/survival
Primary endpoint: Reduction in CEAP clinical class
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Onychomycosis severity index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nail appearance improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Faculty attendance at weekly residency didactic conference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Conference evaluation completion rates
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Average number of faculty and residents tardy to conference
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: relieve soft tissue edema
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vocal fold paralysis (VFP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primary efficacy endpoint incidences
Endpoint domain: Mortality/survival
Primary endpoint: Primary safety endpoint incidences
Endpoint domain: Adverse events/effects
Primary endpoint: Net clinical benefit events
Endpoint domain: Mortality/survival
Primary endpoint: Type 1 anatomical closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: distance traveled during the 6MWT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in intensity of sore throat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes